Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease (EBV + PTLD) after Failure of Rituximab or Rituximab and Chemotherapy

Susan Prockop, MD, Minoti Hiremath, MBBS, PhD, Wei Ye, PhD, Laurence Gamelin, MD, Willis Navarro, MD, Kris Michael Mahadeo, MD

Blood (2019) 134 (Supplement_1): 5326.

https://doi.org/10.1182/blood-2019-129277

Published: 2019

Journal Articles

Biology and management of primary effusion lymphoma

Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi

Blood (2018) 132 (18): 1879–1888.

https://doi.org/10.1182/blood-2018-03-791426

Published: 2018

Journal Articles

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

Erden Atilla, MD, Esmanur Kaplan, MD, Pinar Ataca Atilla, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD

Blood (2016) 128 (22): 5766.

https://doi.org/10.1182/blood.V128.22.5766.5766

Published: 2016

Journal Articles

AMC-053: Pilot Study of an Oncolytic Viral Strategy Using Bortezomib with ICE +/- Rituximab for Relapsed/Refractory HIV+ Lymphomas

Erin Gourley Reid, MD, David Looney, MD, Frank Maldarelli, MD PhD, Ariela Noy, MD, David H. Henry, MD, David M. Aboulafia, MD, Juan Carlos Ramos, MD, Joseph Sparano, MD, Richard F. Ambinder, MD PhD, Jeannette Lee, PhD, Ronald T. Mitsuyasu, MD, William Wachsman, MD PhD

Blood (2016) 128 (22): 786.

https://doi.org/10.1182/blood.V128.22.786.786

Published: 2016

Journal Articles

In Virologically Suppressed HIV+ Patients, High CD4/CD8 Ratio and Length of Treatment Independently Correlate to the Intracellular Content of Proviral HIV-DNA in Different Types of CD4+ T Cells

Andrea Cossarizza, MDPhD, Sara De Biasi, Elena Bianchini, Margherita Digaetano, Simone Pecorini, Marcello Pinti, Lara Gibellini, Vanni Borghi, Cristina Mussini, Milena Nasi

Blood (2016) 128 (22): 3704.

https://doi.org/10.1182/blood.V128.22.3704.3704

Published: 2016

Journal Articles

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Erden Atilla, MD, Pinar Ataca, MD, Sevinc Balli, MD, Baris Isikoglu, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Hamdi Akan, MD

Blood (2015) 126 (23): 5459.

https://doi.org/10.1182/blood.V126.23.5459.5459

Published: 2015

Journal Articles

Exploring the HLA-A Associations in EBV-Associated Classical Hodgkin Lymphoma : HLA-A Genotype Modifies the HLA-A*02:01 Restricted Cytotoxic T-Cell and Cytokine Response to EBV

Katrina Farrell, Karen A McAulay, Dorothy Montgomery, Annette Lake, Ann-Margaret Little, Ruth F Jarrett

Blood (2012) 120 (21): 3635.

https://doi.org/10.1182/blood.V120.21.3635.3635

Published: 2012

Journal Articles

EBV-Specific Micro-RNA Via Exosome: A Key Inter-Cellular machinery between EBV+ Tumor and Tumor-Surrounding Immune Cells?

Kazuaki Yokoyama, Lu Jun, Takae Toyoshima, Hozumi Katsuto, Takashi Yahata, Kiyoshi Ando, Ai Kotani

Blood (2012) 120 (21): 50.

https://doi.org/10.1182/blood.V120.21.50.50

Published: 2012

Journal Articles

Identification of a Costimulation Blockade Resistant Mechanism of Bone Marrow Allograft Rejection Induced by Infection with a Murine EBV Homologue.

Jonathan Beus, Kelly Hamby, Allan D Kirk, MD, PhD, Christian P Larsen, MD, DPhil, Samuel H Speck, PhD, Leslie Kean, MD, PhD

Blood (2010) 116 (21): 1461.

https://doi.org/10.1182/blood.V116.21.1461.1461

Published: 2010

Journal Articles

Latent herpesvirus infection arms NK cells

Douglas W. White, Catherine R. Keppel, Stephanie E. Schneider, Tiffany A. Reese, James Coder, Jacqueline E. Payton, Timothy J. Ley, Herbert W. Virgin, Todd A. Fehniger

Blood (2010) 115 (22): 4377–4383.

https://doi.org/10.1182/blood-2009-09-245464

Published: 2010

Includes: Supplemental data

Journal Articles

Latent Murine Herpesvirus-4 Infection Arms NK Cells.

Douglas W White, MD, PhD, Catherine R Keppel, MS, Stephanie E Schneider, BS, James Coder, Tiffany A Reese, PhD, Jacqueline E. Payton, MD, PhD, Timothy J. Ley, MD, Herbert W Virgin, MD, PhD, Todd A Fehniger, MD, PhD

Blood (2009) 114 (22): 3678.

https://doi.org/10.1182/blood.V114.22.3678.3678

Published: 2009

Journal Articles

The role of the human cytomegalovirus UL111A gene in down-regulating CD4 + T-cell recognition of latently infected cells: implications for virus elimination during latency

Allen K. L. Cheung, David J. Gottlieb, Bodo Plachter, Sandra Pepperl-Klindworth, Selmir Avdic, Anthony L. Cunningham, Allison Abendroth, Barry Slobedman

Blood (2009) 114 (19): 4128–4137.

https://doi.org/10.1182/blood-2008-12-197111

Published: 2009

Journal Articles

Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro

Felicia Goodrum, Matthew Reeves, John Sinclair, Kevin High, Thomas Shenk

Blood (2007) 110 (3): 937–945.

https://doi.org/10.1182/blood-2007-01-070078

Published: 2007

Journal Articles

Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth

Stephanie Tobollik, Linda Meyer, Maike Buettner, Sandra Klemmer, Bettina Kempkes, Elisabeth Kremmer, Gerald Niedobitek, Berit Jungnickel

Blood (2006) 108 (12): 3859–3864.

https://doi.org/10.1182/blood-2006-05-021303

Published: 2006

Journal Articles

Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells

Allen K. L. Cheung, Allison Abendroth, Anthony L. Cunningham, Barry Slobedman

Blood (2006) 108 (12): 3691–3699.

https://doi.org/10.1182/blood-2005-12-026682

Published: 2006

Includes: Supplemental data

Journal Articles

Human Cytomegalovirus Infection of Primitive Hematopoietic Progenitor Cells: A Model for Latency.

Felicia D. Goodrum, Ph.D., Craig T. Jordan, Ph.D., Scott S. Terhune, Ph.D., Kevin P. High, M.D., Thomas Shenk, Ph.D.

Blood (2004) 104 (11): 1703.

https://doi.org/10.1182/blood.V104.11.1703.1703

Published: 2004

Journal Articles

Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors

Barry Slobedman, Edward S. Mocarski, Ann M. Arvin, Elizabeth D. Mellins, Allison Abendroth

Blood (2002) 100 (8): 2867–2873.

https://doi.org/10.1182/blood.V100.8.2867

Published: 2002

Journal Articles

Latent Infection and Reactivation of Human Herpesvirus 6 in Two Novel Myeloid Cell Lines

Masaki Yasukawa, Hideki Ohminami, Eiji Sada, Yoshihiro Yakushijin, Masahiko Kaneko, Kohsuke Yanagisawa, Hidehisa Kohno, Shiro Bando, Shigeru Fujita

Blood (1999) 93 (3): 991–999.

https://doi.org/10.1182/blood.V93.3.991

Published: 1999

Journal Articles

Characterization of a Novel Human Natural Killer-Cell Line (NK-YS) Established From Natural Killer Cell Lymphoma/Leukemia Associated With Epstein-Barr Virus Infection

Junjiro Tsuchiyama, Tadashi Yoshino, Masaharu Mori, Eisaku Kondoh, Takeshi Oka, Tadaatsu Akagi, Akio Hiraki, Hiroyuki Nakayama, Akira Shibuya, Yuxiang Ma, Teruyuki Kawabata, Shigeru Okada, Mine Harada

Blood (1998) 92 (4): 1374–1383.

https://doi.org/10.1182/blood.V92.4.1374

Published: 1998

Journal Articles

Methylation of the Epstein-Barr Virus Genome in Normal Lymphocytes

Keith D. Robertson, Richard F. Ambinder

Blood (1997) 90 (11): 4480–4484.

https://doi.org/10.1182/blood.V90.11.4480

Published: 1997

NARROW

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease (EBV + PTLD) after Failure of Rituximab or Rituximab and Chemotherapy

Biology and management of primary effusion lymphoma

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

AMC-053: Pilot Study of an Oncolytic Viral Strategy Using Bortezomib with ICE +/- Rituximab for Relapsed/Refractory HIV+ Lymphomas

In Virologically Suppressed HIV+ Patients, High CD4/CD8 Ratio and Length of Treatment Independently Correlate to the Intracellular Content of Proviral HIV-DNA in Different Types of CD4+ T Cells

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Exploring the HLA-A Associations in EBV-Associated Classical Hodgkin Lymphoma : HLA-A Genotype Modifies the HLA-A*02:01 Restricted Cytotoxic T-Cell and Cytokine Response to EBV

EBV-Specific Micro-RNA Via Exosome: A Key Inter-Cellular machinery between EBV+ Tumor and Tumor-Surrounding Immune Cells?

Identification of a Costimulation Blockade Resistant Mechanism of Bone Marrow Allograft Rejection Induced by Infection with a Murine EBV Homologue.

Latent herpesvirus infection arms NK cells

Latent Murine Herpesvirus-4 Infection Arms NK Cells.

The role of the human cytomegalovirus UL111A gene in down-regulating CD4 + T-cell recognition of latently infected cells: implications for virus elimination during latency

Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro

Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth

Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells

Human Cytomegalovirus Infection of Primitive Hematopoietic Progenitor Cells: A Model for Latency.

Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors

Latent Infection and Reactivation of Human Herpesvirus 6 in Two Novel Myeloid Cell Lines

Characterization of a Novel Human Natural Killer-Cell Line (NK-YS) Established From Natural Killer Cell Lymphoma/Leukemia Associated With Epstein-Barr Virus Infection

Methylation of the Epstein-Barr Virus Genome in Normal Lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only